509 A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low dose cyclophosphamide for patients with advanced solid tumors

European Journal of Cancer ◽

10.1016/s0959-8049(16)30310-0 ◽

2015 ◽

Vol 51 ◽

pp. S106

Author(s):

Y. Hijikata ◽

T. Okazaki ◽

K. Yamada ◽

K. Tani ◽

M. Murahashi ◽

...

Keyword(s):

Clinical Trial ◽

Cell Therapy ◽

Phase I ◽

Solid Tumors ◽

Low Dose ◽

Immune Cell ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors

Download Full-text

Abstract LB-172: A phase I clinical trial of RNF43 peptide-specific immune cell therapy combined with low-dose cyclophosphamide for patients with advanced solid tumors

10.1158/1538-7445.am2014-lb-172 ◽

2014 ◽

Author(s):

Yasuki Hijikata ◽

Toshihiko Okazaki ◽

Hiroyuki Inoue ◽

Yoshihiro Tanaka ◽

Kenzaburo Tani ◽

...

Keyword(s):

Clinical Trial ◽

Cell Therapy ◽

Phase I ◽

Solid Tumors ◽

Low Dose ◽

Immune Cell ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors

Download Full-text

A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors

PLoS ONE ◽

10.1371/journal.pone.0187878 ◽

2018 ◽

Vol 13 (1) ◽

pp. e0187878 ◽

Cited By ~ 3

Author(s):

Yasuki Hijikata ◽

Toshihiko Okazaki ◽

Yoshihiro Tanaka ◽

Mutsunori Murahashi ◽

Yuichi Yamada ◽

...

Keyword(s):

Clinical Trial ◽

Cell Therapy ◽

Phase I ◽

Solid Tumors ◽

Low Dose ◽

Immune Cell ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors

Download Full-text

A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors

Annals of Oncology ◽

10.1093/annonc/mdy485.011 ◽

2018 ◽

Vol 29 ◽

pp. x14 ◽

Cited By ~ 1

Author(s):

J.K. Schwarze ◽

G. Awada ◽

I. Van Riet ◽

B. Neyns

Keyword(s):

Clinical Trial ◽

Dendritic Cells ◽

Phase I ◽

Solid Tumors ◽

Low Dose ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors ◽

Myeloid Dendritic Cells ◽

Intratumoral Administration

Download Full-text

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial

Cancer Immunology Immunotherapy ◽

10.1007/s00262-018-2288-8 ◽

2019 ◽

Vol 68 (3) ◽

pp. 503-515 ◽

Cited By ~ 9

Author(s):

Charlotte M. Huijts ◽

◽

Sinéad M. Lougheed ◽

Zuhir Bodalal ◽

Carla M. van Herpen ◽

...

Keyword(s):

Clinical Trial ◽

Renal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Low Dose ◽

Immune Cell ◽

Phase I Clinical Trial ◽

Immune Cell Subsets

Download Full-text

Phase I clinical trial of BromoHydrin PyroPhosphate, BrHPP (Phosphostim), a Vγ9Vδ2 T lymphocytes agonist in combination with low dose Interleukin-2 in patients with solid tumors

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.2536 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 2536-2536 ◽

Cited By ~ 8

Author(s):

J. Bennouna ◽

J. Medioni ◽

F. Rolland ◽

J. L. Misset ◽

M. Campone ◽

...

Keyword(s):

Clinical Trial ◽

T Lymphocytes ◽

Phase I ◽

Solid Tumors ◽

Low Dose ◽

Interleukin 2 ◽

Phase I Clinical Trial

Download Full-text

Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.2558 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 2558-2558 ◽

Cited By ~ 2

Author(s):

Jennifer Rachel Eads ◽

Smitha S. Krishnamurthi ◽

Joel N. Saltzman ◽

Neal J. Meropol ◽

Joseph A. Bokar ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Solid Tumors ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors

Download Full-text

Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-005-0134-0 ◽

2005 ◽

Vol 58 (1) ◽

pp. 107-116 ◽

Cited By ~ 4

Author(s):

Joseph P. Eder ◽

David P. Ryan ◽

Leonard Appleman ◽

Andrew X. Zhu ◽

Thomas Puchalski ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Solid Tumors ◽

Intravenous Infusion ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors ◽

Continuous Intravenous Infusion ◽

Farnesyltransferase Inhibitor

Download Full-text

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-0491 ◽

2015 ◽

Vol 22 (6) ◽

pp. 1364-1370 ◽

Cited By ~ 124

Author(s):

Melinda S. Merchant ◽

Matthew Wright ◽

Kristin Baird ◽

Leonard H. Wexler ◽

Carlos Rodriguez-Galindo ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Solid Tumors ◽

Pediatric Patients ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors

Download Full-text

Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model

Oncotarget ◽

10.18632/oncotarget.12668 ◽

2016 ◽

Vol 7 (47) ◽

pp. 77348-77357 ◽

Cited By ~ 10

Author(s):

Si Yeol Song ◽

Kyu-pyo Kim ◽

Seong-Yun Jeong ◽

Jin Park ◽

Jaesook Park ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase I ◽

Solid Tumors ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors ◽

Cancer Model ◽

Preclinical Data ◽

Polymeric Nanoparticle

Download Full-text

Safety and pharmacokinetics of intravenous VEGF Trap in a phase I clinical trial of patients with advanced solid tumors

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3029 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3029-3029 ◽

Cited By ~ 35

Author(s):

J. Dupont ◽

M. L. Rothenberg ◽

D. R. Spriggs ◽

J. M. Cedarbaum ◽

E. S. Furfine ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Solid Tumors ◽

Phase I Clinical Trial ◽

Advanced Solid Tumors ◽

Vegf Trap

Download Full-text